352 related articles for article (PubMed ID: 22481482)
1. Disrupted foveal photoreceptors after combined cystoid spaces and retinal detachment in branch vein occlusion treated with bevacizumab.
Murakami T; Tsujikawa A; Miyamoto K; Sakamoto A; Ogino K; Muraoka Y; Kurashige Y; Yoshimura N
Retina; 2012 Oct; 32(9):1853-61. PubMed ID: 22481482
[TBL] [Abstract][Full Text] [Related]
2. Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion.
Ota M; Tsujikawa A; Murakami T; Yamaike N; Sakamoto A; Kotera Y; Miyamoto K; Kita M; Yoshimura N
Am J Ophthalmol; 2008 Feb; 145(2):273-280. PubMed ID: 18045566
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
Ehlers JP; Decroos FC; Fekrat S
Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
[TBL] [Abstract][Full Text] [Related]
4. Association between foveal microstructure and visual outcome in age-related macular degeneration.
Shin HJ; Chung H; Kim HC
Retina; 2011 Sep; 31(8):1627-36. PubMed ID: 21606888
[TBL] [Abstract][Full Text] [Related]
5. Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion.
Shin HJ; Chung H; Kim HC
Acta Ophthalmol; 2011 Feb; 89(1):e35-40. PubMed ID: 21155986
[TBL] [Abstract][Full Text] [Related]
6. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion.
Yasuda S; Kondo M; Kachi S; Ito Y; Terui T; Ueno S; Terasaki H
Retina; 2011 Jun; 31(6):1075-82. PubMed ID: 21478810
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
8. Changes in visual acuity and foveal photoreceptor integrity in eyes with chronic cystoid macular edema associated with retinal vein occlusion.
Kurashige Y; Tsujikawa A; Murakami T; Miyamoto K; Ogino K; Muraoka Y; Yoshimura N
Retina; 2012 Apr; 32(4):792-8. PubMed ID: 22080912
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis.
Kondo M; Kondo N; Ito Y; Kachi S; Kikuchi M; Yasuma TR; Ota I; Kensaku M; Terasaki H
Retina; 2009 Oct; 29(9):1242-8. PubMed ID: 19672216
[TBL] [Abstract][Full Text] [Related]
10. Highly reflective line in optical coherence tomography images of eyes with macular edema associated with branch retinal vein occlusion.
Hasegawa T; Masuda N; Ogata N
Am J Ophthalmol; 2015 May; 159(5):925-33.e1. PubMed ID: 25644536
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between photoreceptor layer and visual acuity in eyes with persistent cystoid macular edema secondary to branch retinal vein occlusion].
Zou X; Dai RP; Dong FT
Zhonghua Yan Ke Za Zhi; 2010 Nov; 46(11):1006-10. PubMed ID: 21211297
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
14. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
Yamaike N; Tsujikawa A; Sakamoto A; Ota M; Kotera Y; Miyamoto K; Kita M; Yoshimura N
Retina; 2009 Jun; 29(6):757-67. PubMed ID: 19289982
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
[TBL] [Abstract][Full Text] [Related]
16. Correlation of fundus autofluorescence with foveal microstructures and vision in branch retinal vein occlusion.
Park B; Kim J; Chung H; Kim HC
Retina; 2014 Mar; 34(3):531-8. PubMed ID: 24077087
[TBL] [Abstract][Full Text] [Related]
17. Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion.
Kang JW; Lee H; Chung H; Kim HC
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1413-21. PubMed ID: 24577742
[TBL] [Abstract][Full Text] [Related]
18. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab.
Nagaoka T; Sogawa K; Yoshida A
Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136
[TBL] [Abstract][Full Text] [Related]
19. Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.
Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
Ophthalmology; 2012 Dec; 119(12):2587-91. PubMed ID: 22902212
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND
Retina; 2009 Apr; 29(4):511-5. PubMed ID: 19174717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
